標(biāo)題: Titlebook: Cardiovascular Risk in Type 2 Diabetes Mellitus; Assessment and Contr Nicolae Hancu Book 2003 Springer-Verlag Berlin Heidelberg 2003 cardio [打印本頁(yè)] 作者: 太平間 時(shí)間: 2025-3-21 17:27
書(shū)目名稱(chēng)Cardiovascular Risk in Type 2 Diabetes Mellitus影響因子(影響力)
書(shū)目名稱(chēng)Cardiovascular Risk in Type 2 Diabetes Mellitus影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Cardiovascular Risk in Type 2 Diabetes Mellitus網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Cardiovascular Risk in Type 2 Diabetes Mellitus網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Cardiovascular Risk in Type 2 Diabetes Mellitus被引頻次
書(shū)目名稱(chēng)Cardiovascular Risk in Type 2 Diabetes Mellitus被引頻次學(xué)科排名
書(shū)目名稱(chēng)Cardiovascular Risk in Type 2 Diabetes Mellitus年度引用
書(shū)目名稱(chēng)Cardiovascular Risk in Type 2 Diabetes Mellitus年度引用學(xué)科排名
書(shū)目名稱(chēng)Cardiovascular Risk in Type 2 Diabetes Mellitus讀者反饋
書(shū)目名稱(chēng)Cardiovascular Risk in Type 2 Diabetes Mellitus讀者反饋學(xué)科排名
作者: transplantation 時(shí)間: 2025-3-21 21:37 作者: Between 時(shí)間: 2025-3-22 01:11 作者: llibretto 時(shí)間: 2025-3-22 08:11
Gliclazide and Diabetic Angiopathy,ovascular disease is a useful distinction for the purposes of research and debate, although several risk factors and mechanisms appear to be implicated in both patterns of disease. The results of recent intervention trials, including the Kumamoto, UKPDS 33, and Steno 2 studies, concur that tight gly作者: Lineage 時(shí)間: 2025-3-22 09:00
Clinical Experience with Repaglinide, the First Prandial Glucose Regulator in Type 2 Diabetes, short duration of action—is able to limit postprandial blood glucose excursions, and allows convenient administration in a flexible schedule at meal times. Placebo-controlled and comparative studies have demonstrated that prandial repaglinide achieves a high level of overall glycaemic control by sy作者: Hemoptysis 時(shí)間: 2025-3-22 14:03 作者: Hemoptysis 時(shí)間: 2025-3-22 20:20
Hypertension in Type 2 Diabetes Mellitus,disturbances: A defective beta cell function and a decreased insulin sensitivity (insulin resistance) at specific target tissues: skeletal muscle, adipocytes. Type 2 DM, the most common form of Diabetes (over 90% of all cases) has become, as it has been Type 1 DM, a global problem with the character作者: Chameleon 時(shí)間: 2025-3-22 23:27 作者: cunning 時(shí)間: 2025-3-23 03:27
Cardiovascular Risk in Obese Type 2 Diabetes Mellitus Patients,ovascular disease. The key feature which links visceral obesity, Type 2 diabetes mellitus and cardiovascular risk is considered to be insulin resistance. It induces a cluster of metabolic, vascular, prothrombotic anomalies, known as metabolic syndrome. The cardiovascular risk related to metabolic sy作者: Rebate 時(shí)間: 2025-3-23 07:19
The Hypertriglyceridemic Waist Concept: Implication for Evaluation and Management of Cardiovasculareasing prevalence has led the World Health Organization to claim that increased adiposity is the major factor for the development of Type 2 diabetes [3]. However, despite this well established contribution of obesity in the etiology of diabetes, it is also more and more recognized that not every obe作者: evasive 時(shí)間: 2025-3-23 13:19 作者: 阻撓 時(shí)間: 2025-3-23 15:32 作者: 欄桿 時(shí)間: 2025-3-23 19:05 作者: Encoding 時(shí)間: 2025-3-23 23:15 作者: Physiatrist 時(shí)間: 2025-3-24 02:43
Cardiac Autonomic Neuropathy: Is it a Cardiovascular Risk Factor in Type 2 Diabetes,ates vital processes such as heart rate, blood pressure, myocardial contractility and as a consequence plays a pivotal role in the regulation of the cardiovascular system.Cardiac autonomic neuropathy represents a serious complication as it carries an approximately fivefold risk of mortality in patie作者: AND 時(shí)間: 2025-3-24 08:29
Thiazolidinediones in Cardiovascular Risk in Type 2 Diabetes Mellitus,y reduce and retard the microvascular complications. Ultimately however, up to 80% of type 2 diabetics die from macrovascular cardiovascular disease. Insulin resistance, a major pathophysiologic abnormality in type 2 diabetes, is involved in the development of not only hyperglycemia, but also dyslip作者: OVER 時(shí)間: 2025-3-24 12:22 作者: Compassionate 時(shí)間: 2025-3-24 17:24
Cardiac Exploration of Diabetic Patients, neuropathy dysfunction and because these patients are often asymptomatic, the cardiac exploration is essential in the clinical assessment. The noninvasive methods (ECG, echo-Doppler, nuclear perfusion, etc.) are usually sufficient in diagnosis and establishing cardiac disease severity evaluation..T作者: arthroscopy 時(shí)間: 2025-3-24 19:28 作者: Congruous 時(shí)間: 2025-3-25 02:01 作者: Cougar 時(shí)間: 2025-3-25 04:02
ortance of macrovascular disease in persons with type 2 diabetes. In this volume, we present facts that dem- onstrate how important it is to recognize macrovascular disease in these patients in daily practice. This volume has been compiled to help those already involved in dia- betes care, to be mor作者: 不公開(kāi) 時(shí)間: 2025-3-25 08:38
The Method of Fractionary Stepsfor all cardiovascular disease was significantly higher in people with diabetes than in non diabetic individuals (30.4 versus 8.3 deaths per 1000 observation-years respectively, in middle-aged Swedish men) [2].作者: 流眼淚 時(shí)間: 2025-3-25 15:39
Microalbuminuria and Cardiovascular Disease in Type 2 Diabetes,for all cardiovascular disease was significantly higher in people with diabetes than in non diabetic individuals (30.4 versus 8.3 deaths per 1000 observation-years respectively, in middle-aged Swedish men) [2].作者: 松軟 時(shí)間: 2025-3-25 17:32
Book 2003 with type 2 diabetes. In this volume, we present facts that dem- onstrate how important it is to recognize macrovascular disease in these patients in daily practice. This volume has been compiled to help those already involved in dia- betes care, to be more involved in cardiovascular risk control, 作者: FLIRT 時(shí)間: 2025-3-25 21:14
Nonlinear Equations in One Variable,of gliclazide has paralleled this progress in the understanding of pathophysiology, with interest focusing on the potential for this molecule to provide glycemia-independent vascular protection in the management of type 2 diabetic patients.作者: Ganglion-Cyst 時(shí)間: 2025-3-26 04:00
https://doi.org/10.1007/978-94-009-3157-2n individuals with type 2 diabetes lower their weight by eating a diet high in fruits, vegetables, and low-fat dairy foods combined with regular, moderate exercise to reduce hypertension, hyperglycemia, and regain lipid balance.作者: Dorsal-Kyphosis 時(shí)間: 2025-3-26 05:35
Gliclazide and Diabetic Angiopathy,of gliclazide has paralleled this progress in the understanding of pathophysiology, with interest focusing on the potential for this molecule to provide glycemia-independent vascular protection in the management of type 2 diabetic patients.作者: 嚴(yán)厲譴責(zé) 時(shí)間: 2025-3-26 09:33 作者: Diluge 時(shí)間: 2025-3-26 15:21 作者: 鎮(zhèn)痛劑 時(shí)間: 2025-3-26 19:33 作者: 新奇 時(shí)間: 2025-3-26 22:38 作者: Oration 時(shí)間: 2025-3-27 03:29
https://doi.org/10.1007/978-1-4684-6357-6in other known CVD risk factors. However, diabetic status appears to confer risk such that even after correction of other risk factors, the diabetic remains at high risk for macrovascular disease. The excess risk is so high that being diabetic is considered to place a patient in the same risk catego作者: figurine 時(shí)間: 2025-3-27 05:23
Iterative Methods for Nonlinear Systems,ke place during periods of low blood glucose. Data from comparative studies show that repaglinide reduces the risk of major hypoglycaemia by more than 50%, compared with sulphonylureas. This advantage may be even more marked when the patient is free to adopt a flexible/normal meal pattern. To reduce作者: 責(zé)怪 時(shí)間: 2025-3-27 11:09
https://doi.org/10.1007/978-94-010-2565-2 including a complex interplay between a poligenic background, — likewise variable among different ethnic groups —, and a vast array of environmental factors related to inappropriate western-like (“cocacolonization”) lifestyle: excessive caloric intake, lack of physical activity, diet rich in refine作者: BOOR 時(shí)間: 2025-3-27 15:57
A Method for Computation of the Errorgeted and multifactorial interventions. Structured programme as: therapy, education, monitoring, evaluation should be applied. Weight loss is a major therapeutic goal. Lifestyle optimization, through hypocaloric diet and physical activity and specific medication for obesity, are methods to be consid作者: sparse 時(shí)間: 2025-3-27 20:32
Example II: The Neumann Problem]. Android obesity has also been referred to as upper body obesity, central obesity or abdominal obesity. This condition is obviously more frequently observed in men than in women. Gynoid obesity, also referred to as lower body obesity or peripheral obesity, is the typical body fat distribution patt作者: NEEDY 時(shí)間: 2025-3-27 22:13 作者: reserve 時(shí)間: 2025-3-28 04:15
Stability of capillary waves on deep water,s are therefore relevant only in context with hyperreactive platelets and endothelial lesions or dysfunction. Correction of overweight and the improved metabolic control would however diminish the pathologically increased plasma levels of protrombothic hemostatic variables and in association with an作者: Felicitous 時(shí)間: 2025-3-28 07:36 作者: TERRA 時(shí)間: 2025-3-28 13:49 作者: POLYP 時(shí)間: 2025-3-28 15:06
Thom C. Potempa,Mary Fanett Wheelersuggested that Thiazolidinediones have potentially favorable effects on the diabetes associated proath-erogenic metabolic abnormalities including decrease in blood pressure, correction of diabetic dyslipidemia, improvement of fibrinolysis, and decrease in carotid artery intima-media thickness.In thi作者: 種族被根除 時(shí)間: 2025-3-28 19:32 作者: cumber 時(shí)間: 2025-3-29 00:26
The Heavy Burden of Cardiovascular Disease in Type 2 Diabetes, 2 diabetic patients and nondiabetic individuals. The correction of poor glycemic control reduces microvascular complications but its effect on the prevention of cardiovascular disease is more limited. Drug treatment of established cardiovascular disease in patients with type 2 diabetes should follo作者: 使習(xí)慣于 時(shí)間: 2025-3-29 06:01
Atherogenesis in Diabetes,in other known CVD risk factors. However, diabetic status appears to confer risk such that even after correction of other risk factors, the diabetic remains at high risk for macrovascular disease. The excess risk is so high that being diabetic is considered to place a patient in the same risk catego作者: 冒煙 時(shí)間: 2025-3-29 10:51
Clinical Experience with Repaglinide, the First Prandial Glucose Regulator in Type 2 Diabetes,ke place during periods of low blood glucose. Data from comparative studies show that repaglinide reduces the risk of major hypoglycaemia by more than 50%, compared with sulphonylureas. This advantage may be even more marked when the patient is free to adopt a flexible/normal meal pattern. To reduce作者: 運(yùn)動(dòng)吧 時(shí)間: 2025-3-29 13:17 作者: 畫(huà)布 時(shí)間: 2025-3-29 19:04
Cardiovascular Risk in Obese Type 2 Diabetes Mellitus Patients,geted and multifactorial interventions. Structured programme as: therapy, education, monitoring, evaluation should be applied. Weight loss is a major therapeutic goal. Lifestyle optimization, through hypocaloric diet and physical activity and specific medication for obesity, are methods to be consid作者: 打擊 時(shí)間: 2025-3-29 23:09
The Hypertriglyceridemic Waist Concept: Implication for Evaluation and Management of Cardiovascular]. Android obesity has also been referred to as upper body obesity, central obesity or abdominal obesity. This condition is obviously more frequently observed in men than in women. Gynoid obesity, also referred to as lower body obesity or peripheral obesity, is the typical body fat distribution patt作者: Intellectual 時(shí)間: 2025-3-30 00:28 作者: 繁榮地區(qū) 時(shí)間: 2025-3-30 05:41
The Prothrombotic Syndrome in Type 2 Diabetes: Assessment and Control,s are therefore relevant only in context with hyperreactive platelets and endothelial lesions or dysfunction. Correction of overweight and the improved metabolic control would however diminish the pathologically increased plasma levels of protrombothic hemostatic variables and in association with an作者: 沒(méi)血色 時(shí)間: 2025-3-30 10:33
Hyperhomocysteinemia as Cardiovascular Risk Factor in Type 2 Diabetes Mellitus,othelial dysfunction. In general, diabetic patients with associated hyperhomocysteinemia showed higher levels of serum creatinine, and in type 2 diabetic subjects, multiple regression analysis has depicted albumin excretion rate as the parameter with strongest independent association with elevated p作者: trigger 時(shí)間: 2025-3-30 14:13
Cardiac Autonomic Neuropathy: Is it a Cardiovascular Risk Factor in Type 2 Diabetes,rdiac dysfunction to rest or exercise. Severe autonomic neuropathy may be responsible for spontaneous respiratory arrest and unexplained sudden deaths, which are not rare among diabetic patients. A relationship between the presence and/ or severity of CAN and corrected QT interval prolongation is we作者: Adulterate 時(shí)間: 2025-3-30 20:27 作者: Truculent 時(shí)間: 2025-3-30 20:59 作者: 清真寺 時(shí)間: 2025-3-31 04:22 作者: 啞巴 時(shí)間: 2025-3-31 05:33
http://image.papertrans.cn/c/image/221983.jpg作者: 含糊 時(shí)間: 2025-3-31 12:38 作者: gonioscopy 時(shí)間: 2025-3-31 14:38
978-3-642-63946-3Springer-Verlag Berlin Heidelberg 2003作者: 高貴領(lǐng)導(dǎo) 時(shí)間: 2025-3-31 20:11 作者: 悅耳 時(shí)間: 2025-3-31 23:41
Dyslipidemia and Cardiovascular Risk in Diabetes,Diabetes mellitus, due to its rising incidence world wide, and its increased risk for the development of cardiovascular complications, represents a significant public health problem [1]. In this chapter, we will focus on the impact on cardiovascular risk of lipid abnormalities, a frequent finding in type 2 diabetic patients.作者: Perineum 時(shí)間: 2025-4-1 03:38 作者: 摘要記錄 時(shí)間: 2025-4-1 09:26 作者: 記憶法 時(shí)間: 2025-4-1 13:32
Low-Rank Approximation of Tensorsommon in diabetic patients than in nondiabetic subjects. Although several cardiovascular risk factors are abnormal in patients with type 2 diabetes we can not explain the excess of cardiovascular disease among these patients. The most important risk factors for cardiovascular disease in type 2 diabe
